| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_22dac0df31985622b4c1a2ef109cc106 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4985
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0056 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4985 |
| filingDate |
2015-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f5774b44e73e7d4e4e11be53d547f5e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_025a334db51b34552a8d1a7c691c16ec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10b9067a0040a0722d974feec159c017
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e80e437a3b205faabb508b5ef9784ab6 |
| publicationDate |
2016-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2016001143-A1 |
| titleOfInvention |
Orally disintegrating formulations of tadalafil |
| abstract |
The present invention relates to an orally disintegrating pharmaceutical formulation comprising tadalafil or a pharmaceutically acceptable salt thereof and at least one pharmaceutically acceptable excipient. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114948886-A |
| priorityDate |
2014-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |